ZTS – Zoetis Inc.
ZTS — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
4.22
Margin Of Safety %
9
Put/Call OI Ratio
0.46
EPS Next Q Diff
-0.57
EPS Last/This Y
-0.2
EPS This/Next Y
0.33
Price
69.11
Target Price
90.58
Analyst Recom
2.26
Performance Q
-7.59
Upside
14.4%
Beta
0.74
Ticker: ZTS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-09-02 | ZTS | 76.16 | 0.53 | 0.65 | 173750 |
| 2026-09-03 | ZTS | 76.28 | 0.52 | 0.79 | 174214 |
| 2026-09-04 | ZTS | 75.78 | 0.52 | 1.03 | 174576 |
| 2026-09-08 | ZTS | 73.85 | 0.53 | 0.82 | 175544 |
| 2026-09-09 | ZTS | 73.32 | 0.53 | 0.89 | 176238 |
| 2026-09-10 | ZTS | 72.86 | 0.53 | 0.46 | 177303 |
| 2026-09-11 | ZTS | 72.98 | 0.53 | 1.00 | 177547 |
| 2026-09-14 | ZTS | 73.68 | 0.53 | 0.83 | 178516 |
| 2026-09-15 | ZTS | 73.42 | 0.53 | 0.77 | 178612 |
| 2026-09-16 | ZTS | 73.01 | 0.53 | 0.85 | 178879 |
| 2026-09-17 | ZTS | 73.01 | 0.53 | 0.77 | 178658 |
| 2026-09-18 | ZTS | 71.46 | 0.52 | 0.31 | 180101 |
| 2026-09-21 | ZTS | 71.32 | 0.43 | 0.60 | 148076 |
| 2026-09-22 | ZTS | 72.85 | 0.44 | 0.38 | 151060 |
| 2026-09-23 | ZTS | 71.71 | 0.44 | 0.67 | 152579 |
| 2026-09-24 | ZTS | 70.31 | 0.44 | 1.48 | 153223 |
| 2026-09-25 | ZTS | 71.04 | 0.45 | 0.91 | 155992 |
| 2026-09-28 | ZTS | 71.42 | 0.46 | 0.29 | 157111 |
| 2026-09-29 | ZTS | 70.3 | 0.46 | 0.55 | 157069 |
| 2026-09-30 | ZTS | 69.86 | 0.46 | 0.35 | 157649 |
| 2026-10-01 | ZTS | 69.12 | 0.46 | 2.18 | 157752 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-09-02 | ZTS | 76.14 | -11.3 | -602.4 | 6.21 |
| 2026-09-03 | ZTS | 76.28 | -11.3 | -564.6 | 6.21 |
| 2026-09-04 | ZTS | 75.81 | -11.3 | -582.6 | 6.21 |
| 2026-09-08 | ZTS | 73.60 | -11.3 | -637.9 | 6.21 |
| 2026-09-09 | ZTS | 73.28 | -11.3 | -579.4 | 6.21 |
| 2026-09-10 | ZTS | 72.89 | -11.3 | -581.6 | 6.21 |
| 2026-09-11 | ZTS | 72.98 | -11.3 | -564.1 | 6.21 |
| 2026-09-14 | ZTS | 73.67 | -11.3 | -545.3 | 6.21 |
| 2026-09-15 | ZTS | 73.45 | -11.3 | -575.1 | 6.21 |
| 2026-09-16 | ZTS | 73.45 | -11.3 | -575.1 | 6.21 |
| 2026-09-17 | ZTS | 73.01 | -11.3 | -567.7 | 6.21 |
| 2026-09-18 | ZTS | 71.46 | -11.3 | -618.8 | 6.21 |
| 2026-09-21 | ZTS | 71.32 | -11.3 | -570.7 | 6.21 |
| 2026-09-22 | ZTS | 72.76 | -11.3 | -520.7 | 6.21 |
| 2026-09-23 | ZTS | 71.68 | -11.3 | -606.5 | 6.21 |
| 2026-09-24 | ZTS | 70.29 | -11.3 | -611.7 | 6.21 |
| 2026-09-25 | ZTS | 71.05 | -11.3 | -541.9 | 6.21 |
| 2026-09-28 | ZTS | 71.43 | -11.3 | -528.3 | 6.21 |
| 2026-09-29 | ZTS | 70.36 | -11.0 | -576.4 | 6.21 |
| 2026-09-30 | ZTS | 69.86 | -11.0 | -556.0 | 6.21 |
| 2026-10-01 | ZTS | 69.11 | -11.0 | -565.5 | 6.21 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-09-02 | ZTS | 1.24 | -4.24 | 4.07 |
| 2026-09-03 | ZTS | 1.24 | -4.24 | 4.07 |
| 2026-09-04 | ZTS | 1.24 | -4.24 | 4.07 |
| 2026-09-08 | ZTS | 1.24 | -4.24 | 4.07 |
| 2026-09-09 | ZTS | 1.24 | -4.24 | 4.07 |
| 2026-09-10 | ZTS | 1.24 | -4.24 | 4.07 |
| 2026-09-11 | ZTS | 1.24 | -4.24 | 4.71 |
| 2026-09-14 | ZTS | 1.24 | -4.17 | 4.71 |
| 2026-09-15 | ZTS | 1.24 | -4.17 | 4.71 |
| 2026-09-16 | ZTS | 1.24 | -4.17 | 4.71 |
| 2026-09-17 | ZTS | 1.24 | -4.17 | 4.71 |
| 2026-09-18 | ZTS | 1.24 | -4.17 | 4.71 |
| 2026-09-21 | ZTS | 1.24 | -4.10 | 4.71 |
| 2026-09-23 | ZTS | 1.24 | -4.10 | 4.71 |
| 2026-09-24 | ZTS | 1.24 | -4.10 | 4.71 |
| 2026-09-25 | ZTS | 1.24 | -4.10 | 4.22 |
| 2026-09-28 | ZTS | 1.24 | -4.14 | 4.22 |
| 2026-09-29 | ZTS | 1.24 | -4.14 | 4.22 |
| 2026-09-30 | ZTS | 1.24 | -4.14 | 4.22 |
| 2026-10-01 | ZTS | 1.24 | -4.14 | 4.22 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.87
Avg. EPS Est. Current Quarter
1.51
Avg. EPS Est. Next Quarter
1.3
Insider Transactions
1.24
Institutional Transactions
-4.14
Beta
0.74
Average Sales Estimate Current Quarter
2297
Average Sales Estimate Next Quarter
2222
Fair Value
75.6
Quality Score
93
Growth Score
65
Sentiment Score
24
Actual DrawDown %
72.3
Max Drawdown 5-Year %
-71.7
Target Price
90.58
P/E
11.37
Forward P/E
10.67
PEG
3.41
P/S
3
P/B
9.09
P/Free Cash Flow
12.07
EPS
6.08
Average EPS Est. Cur. Y
6.21
EPS Next Y. (Est.)
6.54
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
27.49
Relative Volume
0.96
Return on Equity vs Sector %
57
Return on Equity vs Industry %
77
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
-565.5
◆
ZTS
Healthcare
$69.12
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
34.3
Range 1M
4.7%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-2.4%
EPS NY
3.5%
52W%
0.5%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+20.5% upside
Upside
+20.5%
Quality
93
MoS
9%
ZTS — P/E HistoricalDrug Manufacturers - Specialty & Generic
Zoetis Inc.Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 14500
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
ZTS
Latest News
—
Caricamento notizie per ZTS…
stock quote shares ZTS – Zoetis Inc. Stock Price stock today
news today ZTS – Zoetis Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ZTS – Zoetis Inc. yahoo finance google finance
stock history ZTS – Zoetis Inc. invest stock market
stock prices ZTS premarket after hours
ticker ZTS fair value insiders trading